CAS number
CAS 71751-41-2 Abamectin
CAS 65195-55-3 · CAS 71751-41-2 · EC 265-610-3 · EC 615-339-5 · Index No 606-143-00-0
Where CAS 71751-41-2 appears: every table entry that prints it among its identifiers, in the newest version of each act this record holds, and every recorded change to those entries. Many entries name a group of substances and print no number, so absence here is not absence from the law. Not legal advice.
Where it appears now
CLP Annex VI section 3, Index No 606-143-00-0
Last changed in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names · Annex VI on this site
| Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATEs | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
| 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥ 80 %); [2] | _ [1] 265-610-3 [2] | 71751-41-2 [1] 65195-55-3 [2] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10000 | ||
CLP Annex VI section 3, table 2, Index No 606-143-00-0
Last changed in the version in force , by Regulation (EU) 2017/776, the act that change names · Annex VI on this site
| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|
| 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. Cat. 3; R63 T+; R26/28 T; R48/23/25 N; R50-53 | T+; N R: 63-26/28-48/23/25-50/53 S: 28-36/37-45-60-61 | T; R48/23: C ≥ 5% Xn; R48/20: 0,5% ≤ C <5% N; R50-53: C ≥ 0,0025% N; R51-53: 0,00025% ≤ C<0,0025% R52-53: 0,000025% ≤ C<0,00025% | |
| avermectin B1a (purity ≥ 80%); [2] | 265-610-3 [2] | 65195-55-3 [2] |
Cosmetics Regulation Annex II, Reference number 1548
Last changed in the version in force , by Regulation (EU) 2019/831 and 5 others, the acts that change names · Annex II on this site
| Reference number | Substance identification | ||
|---|---|---|---|
| Chemical name/INN | CAS number | EC number | |
| a | b | c | d |
| 1548 | Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | 71751-41-2 [1] | 615-339-5 [1] |
| Avermectin B1a [2] | 65195-55-3 [2] | 265-610-3 [2] | |
PIC Regulation Annex I, the entry for Abamectin
Last changed in the version in force , by Regulation (EU) 2026/1278, the act that change names · Annex I on this site
| Chemical | CAS No | EC No | CN code | Subcategory | Use limitation | Countries for which no notification is required |
|---|---|---|---|---|---|---|
| Abamectin | 65195-55-3 71751-41-2 | 265-610-3 — | ex29419000 ex38089990 | p(2) | b |
Look up a number
Type a CAS or EC number, with or without its hyphens, or an Index No into the search box at the top of the page: it reads 50000 as CAS 50-00-0. Every number is also listed by act on the substances page.
Its history
· amended · PIC Regulation Annex I, the entry for Abamectin
Recorded in the version in force , by Regulation (EU) 2026/1278, the act that change names. The change on its version page
| Identifiers | Version | Chemical | CAS No | EC No | CN code | Subcategory | Use limitation | Countries for which no notification is required |
|---|---|---|---|---|---|---|---|---|
| AbamectinCAS 65195-55-3CAS 71751-41-2EC 265-610-3 | Before | Abamectin | 71751-41-2 | ex38089990 | p(2) | b | ||
| After | Abamectin | 65195-55-3 71751-41-2 | 265-610-3 — | ex29419000 ex38089990 | p(2) | b |
· added · PIC Regulation Annex I, the entry for Abamectin
Recorded in the version in force , by Regulation (EU) 2024/3199, the act that change names. The change on its version page
| Identifiers | Chemical | CAS No | EC No | CN code | Subcategory | Use limitation | Countries for which no notification is required |
|---|---|---|---|---|---|---|---|
| AbamectinCAS 71751-41-2 | Abamectin | 71751-41-2 | ex38089990 | p(2) | b |
· amended · CLP Annex VI section 3, Index No 606-143-00-0
Recorded in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names. The change on its version page
| Identifiers | Version | Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 606-143-00-0CAS 65195-55-3CAS 71751-41-2EC 265-610-3 | Before | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1;
H372: C ≥ 5 %
STOT RE 2;
H373: 0,5 % | ||
| After | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]avermectin B1a (purity ≥ 80 %); [2] | _ [1]265-610-3 [2] | 71751-41-2 [1]65195-55-3 [2] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10000 | |||
· added · Cosmetics Regulation Annex II, Reference number 1548
Recorded in the version in force , by Regulation (EU) 2019/831 and 5 others, the acts that change names. The change on its version page
| Identifiers | Reference number | Substance identification | ||
|---|---|---|---|---|
| Chemical name/INN | CAS number | EC number | ||
| a | b | c | d | |
| Reference number 1548CAS 65195-55-3CAS 71751-41-2EC 265-610-3EC 615-339-5 | 1548 | Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | 71751-41-2 [1] | 615-339-5 [1] |
| Avermectin B1a [2] | 65195-55-3 [2] | 265-610-3 [2] | ||
· amended · CLP Annex VI section 3, Index No 606-143-00-0
Recorded in the version in force , by Regulation (EU) 2017/776, the act that change names. Only spacing, dash forms or accents differ. The change on its version page
| Identifiers | Version | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATE | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 606-143-00-0CAS 65195-55-3CAS 71751-41-2EC 265-610-3 | Before | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C<5 % M = 10000 | ||
| avermectin B1a (purity | 265-610-3 [2] | 65195-55-3 [2] | ||||||||||
| After | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C<5 % M = 10000 | |||
| avermectin B1a (purity ≥ 80 %); [2] | 265-610-3 [2] | 65195-55-3 [2] | ||||||||||
· amended · CLP Annex VI section 3, table 2, Index No 606-143-00-0
Recorded in the version in force , by Regulation (EU) 2017/776, the act that change names. Only spacing, dash forms or accents differ. The change on its version page
| Identifiers | Version | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Index No 606-143-00-0CAS 65195-55-3CAS 71751-41-2EC 265-610-3 | Before | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. Cat. 3; R63 T+; R26/28 T; R48/23/25 N; R50-53 | T+; N R: 63-26/28-48/23/25-50/53 S: 28-36/37-45-60-61 | T; R48/23: C ≥ 5% Xn; R48/20: 0,5% ≤ C <5% N; R50-53: C ≥ 0,0025% N; R51-53: 0,00025% ≤ C<0,0025% R52-53: 0,000025% ≤ C<0,00025% | |
| avermectin B1a (purity | 265-610-3 [2] | 65195-55-3 [2] | |||||||
| After | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. Cat. 3; R63 T+; R26/28 T; R48/23/25 N; R50-53 | T+; N R: 63-26/28-48/23/25-50/53 S: 28-36/37-45-60-61 | T; R48/23: C ≥ 5% Xn; R48/20: 0,5% ≤ C <5% N; R50-53: C ≥ 0,0025% N; R51-53: 0,00025% ≤ C<0,0025% R52-53: 0,000025% ≤ C<0,00025% | ||
| avermectin B1a (purity ≥ 80%); [2] | 265-610-3 [2] | 65195-55-3 [2] |
· added · CLP Annex VI section 3, Index No 606-143-00-0
Recorded in the version in force , by Regulation (EU) No 487/2013 and 4 others, the acts that change names. The change on its version page
| Identifiers | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | |||||||
| Index No 606-143-00-0CAS 65195-55-3CAS 71751-41-2EC 265-610-3 | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 | H361d H300 H330 H372 (nervous system) H400 H410 | GHS06 GHS08 GHS09 Dgr | H361d H300 H330 H372 (nervous system) H410 | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C<5 % M = 10000 | ||
| avermectin B1a (purity ≥80 %); [2] | 265-610-3 [2] | 65195-55-3 [2] | |||||||||
· added · CLP Annex VI section 3, table 2, Index No 606-143-00-0
Recorded in the version in force , by Regulation (EU) No 487/2013 and 4 others, the acts that change names. The change on its version page
| Identifiers | Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|---|
| Index No 606-143-00-0CAS 65195-55-3CAS 71751-41-2EC 265-610-3 | 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. Cat. 3; R63 T+; R26/28 T; R48/23/25 N; R50-53 | T+; N R: 63-26/28-48/23/25-50/53 S: 28-36/37-45-60-61 | T; R48/23: C ≥ 5% Xn; R48/20: 0,5% ≤ C <5% N; R50-53: C ≥ 0,0025% N; R51-53: 0,00025% ≤ C<0,0025% R52-53: 0,000025% ≤ C<0,00025% | |
| avermectin B1a (purity ≥80%); [2] | 265-610-3 [2] | 65195-55-3 [2] |
Sources
- CLP: every version the record holds; rows read from EUR-Lex consolidated version 02008R1272-20270101, in force 1 January 2027 (external, EUR-Lex)
- Cosmetics Regulation: every version the record holds; rows read from EUR-Lex consolidated version 02009R1223-20260518, in force 18 May 2026 (external, EUR-Lex)
- PIC Regulation: every version the record holds; rows read from EUR-Lex consolidated version 02012R0649-20261001, in force 1 October 2026 (external, EUR-Lex)